Nukemed Technologies, Inc.

About Nukemed Technologies, Inc.

Nukemed Technologies, Inc. sits in Other / Uncategorized, a segment Bracken sees as structurally important to the radiopharma value chain.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• Imaging Wire · 2026-09-28
  Nukemed Technologies Inc closes Series C round to scale radiopharma manufacturing
  The work builds on more than a decade of radiochemistry collaboration.
• STAT News · 2026-10-23
  Nukemed Technologies Inc publishes dosimetry data at SNMMI 2026
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Nuclear Medicine Today · 2026-07-02
  Nukemed Technologies Inc files IND for next-generation PSMA-targeted agent
  The announcement comes amid tightening Mo-99 and Lu-177 supply.
• PR Newswire · 2026-04-09
  Nukemed Technologies Inc partners with academic center on Actinium-225 program
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.